Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 18, 2026 | Moda Health | Imjudo (tremelimumab-actl) | Criteria changed |
| May 18, 2026 | Moda Health | Hyaluronic Acid Derivatives: Durolane, Euflexxa, Gel-One, GelSyn-3, GenVisc 850, Hyalgan, Hymovis, Monovisc, Orthovisc, Supartz/Supartz FX, Synojoynt, Synvisc, Synvisc-One, Triluron, TriVisc, VISCO-3, & sodium hyaluronate 1% | Criteria changed |
| May 18, 2026 | Moda Health | Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) | Criteria changed |
| May 18, 2026 | Moda Health | Hemlibra (emicizumab-kxwh) | Criteria changed |
| May 18, 2026 | Moda Health | Hemgenix (etranacogene dezaparvovec-drlb) | Criteria changed |
| May 18, 2026 | Moda Health | Halaven (eribulin) | Criteria changed |
| May 18, 2026 | Moda Health | Givlaari (givosiran) | Criteria changed |
| May 18, 2026 | Moda Health | Gazyva (obinutuzumab) | Criteria changed |
| May 18, 2026 | Moda Health | Gamifant (emapalumab-lzsg) | Criteria changed |
| May 18, 2026 | Moda Health | Feraheme (ferumoxytol) | Criteria changed |
| May 18, 2026 | Moda Health | Fasenra (benralizumab) | Criteria changed |
| May 18, 2026 | Moda Health | Factor XIII Concentrate, human (Corifact) | Criteria changed |
| May 18, 2026 | Moda Health | Factor VIII/VWF Complex: Alphanate, Humate-P, and Wilate | Criteria changed |
| May 18, 2026 | Moda Health | Factor V Leiden Thrombophilia | Criteria changed |
| May 18, 2026 | Moda Health | Fabrazyme (agalsidase beta) | Criteria changed |
| May 18, 2026 | Moda Health | Extended Half-life Factor VIII Products: Altuviiio, Adynovate, Eloctate, Esperoct and Jivi | Criteria changed |
| May 18, 2026 | Moda Health | Extended Half-life Factor IX Products: Alprolix, Idelvion, and Rebinyn | Criteria changed |
| May 18, 2026 | Moda Health | Evkeeza (evinacumab-dgnb) | Criteria changed |
| May 18, 2026 | Moda Health | Evenity (romosozumab-aqqg) | Criteria changed |
| May 18, 2026 | Moda Health | Erbitux (cetuximab) | Criteria changed |
| May 18, 2026 | Moda Health | Epoetin alfa: Epogen; Procrit; Retacrit | Criteria changed |
| May 18, 2026 | Moda Health | Epkinly (epcoritamab-bysp) | Criteria changed |
| May 18, 2026 | Moda Health | Entyvio (vedolizumab) | Criteria changed |
| May 18, 2026 | Moda Health | Enjaymo (sutimlimab-jome) | Criteria changed |
| May 18, 2026 | Moda Health | Enhertu (fam-trastuzumab deruxtecan-nxki) | Criteria changed |
| May 18, 2026 | Moda Health | Encelto (revakinagene taroretcel-lwey) | Criteria changed |
| May 18, 2026 | Moda Health | Emrelis (telisotuzumab vedotin-tllv) | Criteria changed |
| May 18, 2026 | Moda Health | Empliciti (elotuzumab) | Criteria changed |
| May 18, 2026 | Moda Health | Elzonris (tagraxofusp-erzs) | Criteria changed |
| May 18, 2026 | Moda Health | Elrexfio (elranatamab-bcmm) | Criteria changed |
| May 18, 2026 | Moda Health | Elfabrio (pegunigalsidase alfa-iwxj) | Criteria changed |
| May 18, 2026 | Moda Health | Elevidys (delandistrogene moxeparvovec-rokl) | Criteria changed |
| May 18, 2026 | Moda Health | Elelyso (taliglucerase alfa) | Criteria changed |
| May 18, 2026 | Moda Health | Elaprase (idursulfase) | Criteria changed |
| May 18, 2026 | Moda Health | Elahere (mirvetuximab soravtansine-gynx) | Criteria changed |
| May 18, 2026 | Moda Health | Eculicumab: Soliris; Bkemv; Epysqli | Criteria changed |
| May 18, 2026 | Moda Health | Dysport (abobotulinumtoxinA) | Criteria changed |
| May 18, 2026 | Moda Health | Denosumab: Prolia; Jubbonti; Ospomyv; Stoboclo; Denosumab-dssb; Conexxence; Denosumab-bnht; Xgeva; Wyost; Xbryk; Osenvelt; Bomyntra | Criteria changed |
| May 18, 2026 | Moda Health | Daxxify (daxibotulinumtoxinA) | Criteria changed |
| May 18, 2026 | Moda Health | Datroway (datopotamab deruxtecan-dlnk) | Criteria changed |
| May 18, 2026 | Moda Health | Darzalex Faspro (daratumumab and hyaluronidase-fihj) | Criteria changed |
| May 18, 2026 | Moda Health | Darzalex (daratumumab) | Criteria changed |
| May 18, 2026 | Moda Health | Danyelza (naxitamab-gqgk) | Criteria changed |
| May 18, 2026 | Moda Health | Cyramza (ramucirumab) | Criteria changed |
| May 18, 2026 | Moda Health | Crysvita (burosumab-twza) | Criteria changed |
| May 18, 2026 | Moda Health | Cosentyx (secukinumab) | Criteria changed |
| May 18, 2026 | Moda Health | Cosela (trilaciclib) | Criteria changed |
| May 18, 2026 | Moda Health | Corticotropin-ACTH: Acthar Gel (repository corticotropin injection) Cortrophin Gel (repository corticotropin injection) | Criteria changed |
| May 18, 2026 | Moda Health | Columvi (glofitamab-gxbm) | Criteria changed |
| May 18, 2026 | Moda Health | Coagulation Factor XIII A-Subunit, recombinant (Tretten) | Criteria changed |